Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 7

1.

Quantitative PET imaging of Met-expressing human cancer xenografts with 89Zr-labelled monoclonal antibody DN30.

Perk LR, Stigter-van Walsum M, Visser GW, Kloet RW, Vosjan MJ, Leemans CR, Giaccone G, Albano R, Comoglio PM, van Dongen GA.

Eur J Nucl Med Mol Imaging. 2008 Oct;35(10):1857-67. doi: 10.1007/s00259-008-0774-5. Epub 2008 May 20.

PMID:
18491091
2.

Invasive growth: a MET-driven genetic programme for cancer and stem cells.

Boccaccio C, Comoglio PM.

Nat Rev Cancer. 2006 Aug;6(8):637-45. Review.

PMID:
16862193
3.

Ab-induced ectodomain shedding mediates hepatocyte growth factor receptor down-regulation and hampers biological activity.

Petrelli A, Circosta P, Granziero L, Mazzone M, Pisacane A, Fenoglio S, Comoglio PM, Giordano S.

Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):5090-5. Epub 2006 Mar 17.

4.

C-Met overexpression in node-positive breast cancer identifies patients with poor clinical outcome independent of Her2/neu.

Lengyel E, Prechtel D, Resau JH, Gauger K, Welk A, Lindemann K, Salanti G, Richter T, Knudsen B, Vande Woude GF, Harbeck N.

Int J Cancer. 2005 Feb 10;113(4):678-82.

5.

Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer.

Di Renzo MF, Olivero M, Giacomini A, Porte H, Chastre E, Mirossay L, Nordlinger B, Bretti S, Bottardi S, Giordano S, et al.

Clin Cancer Res. 1995 Feb;1(2):147-54.

6.

Overexpression of the c-MET/HGF receptor in human thyroid carcinomas derived from the follicular epithelium.

Di Renzo MF, Olivero M, Serini G, Orlandi F, Pilotti S, Belfiore A, Costantino A, Vigneri R, Angeli A, Pierotti MA, et al.

J Endocrinol Invest. 1995 Feb;18(2):134-9. No abstract available.

PMID:
7629381
7.

Early and late events in the development of human breast cancer.

Smith HS, Stern R, Liu E, Benz C.

Basic Life Sci. 1991;57:329-37; discussion 337-40. Review.

PMID:
1814293

Supplemental Content

Support Center